Vimarsana
Biggest News Aggregation in the World

Page 3 - Gem Global Yield News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Gem Global Yield. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Gem Global Yield Today - Breaking & Trending Today

Sable to undertake rights issue at R1 a share followed by transaction at R5 a share - Vimarsana News

Sable to undertake rights issue at R1 a share followed by transaction at R5 a share

The rights issue that Johannesburg Stock Exchange-listed Sable Exploration and Mining is to undertake at R1 a share will be followed immediately by a transaction at R5 a share, giving an immediate fivefold uplift to the shareholders of the company. This follows mining company Magni Investment Holdings announcing its intention to acquire a majority stake in Sable Exploration and Mining – formerly Middle East Diamond Resources – and its subsidiaries.

Health startup BlueSemi to go public, secures $69 M capital commitment from GEM - Vimarsana News

Health startup BlueSemi to go public, secures $69 M capital commitment from GEM

Prepares to launch its flagship consumer health-tech product, which measures six key vitals like blood glucose, ECG, BP, HR, SPO2, and temperature in just 60 seconds

Relief Reports 2020 Financial Results and Provides Business Update - Vimarsana News

Relief Reports 2020 Financial Results and Provides Business Update

Press release content from Accesswire. The AP news staff was not involved in its creation. Relief Reports 2020 Financial Results and Provides Business Update April 15, 2021 GMT GENEVA, SWITZERLAND / ACCESSWIRE / April 15, 2021 / RELIEF THERAPEUTICS Holding AG (SIX:RLF)(OTCQB:RLFTF) (“Relief” or the “Company”), a biopharmaceutical company with its lead compound RLF-100TM (aviptadil) in advanced clinical development to treat COVID-19 induced lung injury, today announced its 2020 financial results for the year ended December 31, 2020 and provided a business update. “The past year has b...

Source: apnews.com
Relief Therapeutics Holding AG: Relief Reports 2020 Financial Results and Provides Business Update - Vimarsana News

Relief Therapeutics Holding AG: Relief Reports 2020 Financial Results and Provides Business Update

Relief Therapeutics Holding AG: Relief Reports 2020 Financial Results and Provides Business Update Relief" or the " Company"), a biopharmaceutical company with its lead compound RLF-100 TM (aviptadil) in advanced clinical development to treat COVID-19 induced lung injury, today announced its 2020 financial results for the year ended December 31, 2020 and provided a business update. "The past year has been an incredibly productive and rewarding one for all of us at Relief," said Raghuram (Ram) Selvaraju, Chairman of the Board. "We have had an opportunity to make a true difference in fighting ...